2016
DOI: 10.15252/embr.201540984
|View full text |Cite
|
Sign up to set email alerts
|

Feedback regulation between atypical E2Fs and APC / C C dh1 coordinates cell cycle progression

Abstract: E2F transcription factors control the oscillating expression pattern of multiple target genes during the cell cycle. Activator E2Fs, E2F1-3, induce an upswing of E2F targets, which is essential for the G1-to-S phase transition, whereas atypical E2Fs, E2F7 and E2F8, mediate a downswing of the same targets during late S, G2, and M phases. Expression of atypical E2Fs is induced by E2F1-3, but it is unknown how atypical E2Fs are inactivated in a timely manner. Here, we demonstrate that E2F7 and E2F8 are substrates… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
9
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 28 publications
(12 citation statements)
references
References 52 publications
3
9
0
Order By: Relevance
“…Further investigations are required to examine how and when E2Fs are degraded, but studies from our group and others provide evidence that atypical E2Fs are degraded by the APC/C Cdh1 complex. 43 , 44 These findings might open new avenues for therapeutic approaches to inhibit abundant E2F activity during tumorigenesis. Future studies are required to investigate how the activity of activator E2Fs and atypical E2Fs can be optimally manipulated to inhibit tumor growth for different cancer types.…”
Section: Discussionmentioning
confidence: 98%
“…Further investigations are required to examine how and when E2Fs are degraded, but studies from our group and others provide evidence that atypical E2Fs are degraded by the APC/C Cdh1 complex. 43 , 44 These findings might open new avenues for therapeutic approaches to inhibit abundant E2F activity during tumorigenesis. Future studies are required to investigate how the activity of activator E2Fs and atypical E2Fs can be optimally manipulated to inhibit tumor growth for different cancer types.…”
Section: Discussionmentioning
confidence: 98%
“…Besides transcriptional mechanisms, post-transcriptional regulation is known to play an important role in the temporal control of E2F-dependent transcription. Ubiquitin-mediated protein degradation has been proposed to regulate the activity of several E2Fs in vitro (Boekhout et al, 2016; Marti et al, 1999; Ping et al, 2012). Whereas mRNA levels of E2F activators and atypical repressors increased similarly as cells moved from G 0 to G 1 , S-G 2 , and M, peak protein levels of E2F3A and E2F8 were clearly temporally distinct during the cell cycle, with only a partial overlap during S phase.…”
Section: Discussionmentioning
confidence: 99%
“…In exponentially proliferating cells, E2F1 is targeted for degradation by APC/C Cdc20 during prometaphase, and by APC/C Cdh1 in the late M and early G1 phases [ 22 , 24 ]. APC/C Cdh1 also regulates the stability of E2F3, E2F7 and E2F8 during normal cell cycle progression in a variety of cell types [ 36 , 37 ].…”
Section: Discussionmentioning
confidence: 99%